Latest Breaking News On - Jiwen zhang - Page 1 : comparemela.com
Form 425 Renovacor, Inc Filed by: Renovacor, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form 425 Renovacor, Inc Filed by: Renovacor, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BioSpace Movers & Shakers, July 16
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Axion BioSystems Announces Formation of Scientific Advisory Board
April 20, 2021 GMT
ATLANTA (BUSINESS WIRE) Apr 20, 2021
Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells
in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder and Chief Technology Officer, and will work closely with Axion BioSystems’ management team to help identify and prioritize Axion’s next generation of bioelectronic products.
COVID-19 And Beyond: Perspectives From A Regulatory Affairs Professional
By Jiwen Zhang, VP, Regulatory Affairs, Passage Bio
Disclaimer:
The views, thoughts, and opinions expressed in the text belong solely to the author, and not necessarily to the author s employer, organization, committee, or other group or individual.
When the bell rang at the New Year’s Eve, the year of 2020, as the number symbolizes, seemed especially exciting and promising. Then COVID 19 hit.
COVID 19 has brought about many disruptions. Delays are happening in research and development, manufacturing, supply chain, almost all the components essential to drug development that ultimately lead to regulatory decisions and patient access to innovative drugs. Interactions with regulatory agencies have become unpredictable with longer wait to hear back from agencies or review teams that are critical to move along the development process. In some way, delays in agency interactions is inevitable since interaction